Deregulation of lysophosphatidic acid metabolism in oral cancer promotes cell migration via the up-regulation of COX-2

PeerJ

Jason P. Mansell¹  May Leng Tan²  Ian C. Paterson²  Lee Fah Yap²  Mariati Abdul Rahman²  Wen Lin Chai³  Robert J. Hollows⁴  Steven P. Johnson⁵ 

[1]Department of Applied Sciences, University of the West of England, Bristol, United Kingdom

[2]Department of Oral and Craniofacial Sciences, University of Malaya, Kuala Lumpur, Malaysia

[3]Department of Restorative Dentistry, University of Malaya, Kuala Lumpur, Malaysia

[4]Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom

[5]North Devon Healthcare NHS Trust, Barnstable, United Kingdom

关键词: LPA;    OSCC;    Migration;    Invasion;    Radio-resistance;    COX-2;   

DOI  :  10.7717/peerj.10328

来源: DOAJ

【 摘 要 】

Oral squamous cell carcinoma (OSCC) is the sixth most common cancer worldwide and accounts for 300,000 new cases yearly. The five-year survival rate is approximately 50% and the major challenges to improving patient prognosis include late presentation, treatment resistance, second primary tumours and the lack of targeted therapies. Therefore, there is a compelling need to develop novel therapeutic strategies. In this study, we have examined the effect of lysophosphatidic acid (LPA) on OSCC cell migration, invasion and response to radiation, and investigated the contribution of cyclooxygenase-2 (COX-2) in mediating the tumour promoting effects of LPA. Using the TCGA data set, we show that the expression of the lipid phosphate phosphatases (LPP), LPP1 and LPP3, was significantly down-regulated in OSCC tissues. There was no significant difference in the expression of the ENPP2 gene, which encodes for the enzyme autotaxin (ATX) that produces LPA, between OSCCs and control tissues but ENPP2 levels were elevated in a subgroup of OSCCs. To explore the phenotypic effects of LPA, we treated OSCC cell lines with LPA and showed that the lipid enhanced migration and invasion as well as suppressed the response of the cells to irradiation. We also show that LPA increased COX-2 mRNA and protein levels in OSCC cell lines and inhibition of COX-2 activity with the COX-2 inhibitor, NS398, attenuated LPA-induced OSCC cell migration. Collectively, our data show for the first time that COX-2 mediates some of the pro-tumorigenic effects of LPA in OSCC and identifies the ATX-LPP-LPA-COX-2 pathway as a potential therapeutic target for this disease.

【 授权许可】

Unknown